Press Kit

Our mission at ProTom International is to transform cancer treatment by expanding the accessibility of proton therapy and by developing proton tomography technology.

The Radiance 330® Proton Therapy System has driven more than 52 patent applications and has been called the future of proton therapy technology.

Press Assets.

Images

The Radiance 330® Proton Therapy System

Stephen Spotts, President and Chief Executive Officer

Videos

The Radiance 330® Proton Therapy System

Installation of the Radiance 330® Proton Therapy System

Logo

ProTom Logo

Brochure

Radiance 330® brochure

Proton Therapy Research

 Clinical Efficacy of Proton Therapy


Contact: press@protominternational.com